
Morphic Medical Reshuffles Board Amid European Expansion
Following the CE Mark approval of its flagship diabetes treatment, Boston-based Morphic Medical has overhauled its leadership team. The company appointed Dr. Terri Cooper as Chair of the Board and added Craig Richardson as a non-executive director to spearhead efforts in international market access and health economics.

























